$308M
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | PCVX Vaxcyte Inc | 1.4M | +3.9% | $83M | 26.9% |
| 2 | ARQT Arcutis Biotherapeutics Inc | 1.3M | −6.7% | $33M | 10.8% |
| 3 | TRVI Trevi Therapeutics Inc | 1.7M | +12.2% | $33M | 10.6% |
| 4 | AVALYN PHARMACEUTICALS INC Avalyn Pharmaceuticals Inc | 966,792 | — | $32M | 10.3% |
| 5 | EVMN Evommune Inc | 1.9M | +0.0% | $26M | 8.3% |
| 6 | MPLT Maplight Therapeutics Inc | 611,446 | −0.0% | $22M | 7.1% |
| 7 | OCS Oculis Holding Ag | 1.5M | −10.4% | $21M | 6.8% |
| 8 | BIOA Bioage Labs Inc | 653,374 | +0.0% | $16M | 5.2% |
| 9 | IMNM Immunome Inc | 732,512 | +0.0% | $16M | 5.0% |
| 10 | ZBIO Zenas Biopharma Inc | 490,766 | −17.1% | $12M | 4.0% |
| 11 | AVTX Avalo Therapeutics Inc | 434,033 | +46.7% | $8M | 2.6% |
| 12 | RLYB Rallybio Corp | 300,579 | +0.0% | $5M | 1.6% |
| 13 | RXRX Recursion Pharmaceuticals In | 595,518 | +0.0% | $2M | 0.7% |